TransMedics Group had its Relative Strength (RS) Rating upgraded from 78 to 86 Monday.
Looking For The Best Stocks To Buy And Watch? Start Here
This exclusive rating from Investor's Business Daily measures share price action with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the last 52 weeks stacks up against all the other stocks in our database.
History shows that the best stocks often have an RS Rating north of 80 as they begin their biggest climbs.
While TransMedics Group is not near an ideal buy zone right now, see if it is able to form and break out from a proper base.
Earnings growth rose last quarter from 0% to 58%, but sales fell from 64% to 50%. Keep an eye out for the company's next round of numbers on or around May 6.
TransMedics Group holds the No. 12 rank among its peers in the Medical-Products industry group. Boston Scientific, Pro-Dex and Penumbra are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Price Performance?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
